#Bone Densitometers market Growth

[healthcarehubhh]

The Bone Densitometers Market will grow at highest pace owing to rising prevalence of osteoporosis

The bone densitometers market comprises devices that utilize X-ray technologies such as dual-energy X-ray absorptiometry (DEXA) and quantitative computed tomography (QCT) to measure bone mineral density (BMD). DEXA is considered the gold standard for clinical diagnosis of osteoporosis and is highly precise for assessing fracture risk. It offers quick and easy scanning to evaluate BMD at the hip and spine. The growing prevalence of osteoporosis due to sedentary lifestyles and aging populations worldwide has significantly driven the demand for bone densitometers for diagnosis and monitoring of the condition.

The Global Bone Densitometers Market is estimated to be valued at US$ 313.05 Mn in 2024 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023 to 2030. Key Takeaways Key players operating in the bone densitometers are GE Healthcare, Hologic, Inc., Swissray Global Healthcare Holding, and BeamMed Ltd. GE Healthcare offers a wide range of DEXA and QCT bone densitometers under the Discovery and Horizon brands. Hologic Inc. provides DEXA systems such as Horizon Wi, Horizon Lumbar Spine, and Horizon Advance that have received FDA clearance. The rising geriatric population suffering from bone-related disorders is a major factor fueling demand. As per the United Nations, by 2050, one in six people in the world will be over age 65. The number of hip fractures globally is projected to rise from 1.7 million in 1990 to 6.3 million by 2050. Technological advancements are allowing greater precision and efficiency. Newer DEXA systems feature enhanced imaging capabilities, automated analysis, and wireless connectivity for data sharing. Osteoporosis screening programs in various countries are also raising awareness about early diagnosis. Market Trends Rising remote diagnosis: There is an increased focus on remote diagnosis of osteoporosis using portable DEXA devices or home-based monitoring systems connected via the internet. This trend is driven by the need for convenient solutions amidst healthcare resource constraints. Growing Asia Pacific market: The Asia Pacific region is witnessing rapid growth in geriatric population and increased prevalence of osteoporosis. This will drive the sales of bone density assessment devices in countries like China and India in the coming years. Market Opportunities Low-cost devices: There is scope for manufacturers to offer more affordable options to expand diagnosis in developing nations and rural areas with limited access currently. Multi-utility platforms: Developing multi-utility devices capable of bone density assessment along with other tests can increase adoption. This integrated approach saves on equipment costs for healthcare facilities. Impact of COVID-19 on Bone Densitometers Market Growth The COVID-19 pandemic has significantly impacted the bone densitometers market. During the initial outbreak, several countries announced complete lockdowns which led to the temporary closure of healthcare facilities including diagnostic centers. This reduced the volume of bone density tests being conducted using bone densitometers, impacting the revenues of market players. With people staying indoors, osteoporosis screening also saw a decline. However, as lockdowns have gradually eased in different parts of the world, the market is witnessing a recovery. There is growing emphasis on preventive healthcare and management of chronic diseases. This has boosted the importance of bone health monitoring. Several healthcare providers are taking necessary safety precautions while conducting bone mineral density tests. Telehealth solutions are also being leveraged to continue serving patients virtually during such crises.

[tamanna31]

Sinus Dilation Devices Market Size, Share, Growth, Analysis Forecast to 2030

Sinus Dilation Devices Industry Overview

The global sinus dilation devices market size was valued at USD 2.74 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.6% from 2023 to 2030.

The high preference for minimally invasive procedures, favorable reimbursement scenarios, rising awareness about the advantages of balloon sinuplasty over other conventional techniques, and the prevalence of chronic sinusitis are the major factors fostering the market growth. Developing advanced surgery techniques helps increase the market dynamics by replacing traditional procedures.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

Technological advancements, such as surgical laser technologies, in sinus surgery ensure minimal ablation and have fewer side effects. Decreased turnaround time enables these procedures to be performed in outpatient departments. For instance, in 2022, the National Health Service (NHS) introduced an innovative laser treatment for patients with epilepsy. This pioneering therapy utilizes lasers to target and treat areas of the brain that cause seizures, providing a new and advanced approach to managing epilepsy and improving patients' quality of life.

The COVID-19 pandemic led to interruptions in routine patient care. Many healthcare organizations have canceled routine clinic visits and elective surgeries to increase and maintain the availability of intensive care and inpatient care beds and have reorganized medical and nursing staff. This has particularly interrupted care for patients with chronic rhinitis. The patients opted for teleconsultations and temporary options for sinus-related problems.

For instance, in Canada, there was a significant decline in the number of surgeries during the first 31 months of the pandemic, amounting to approximately 937,000 fewer surgeries (14%) compared to the pre-pandemic period. These figures were determined by comparing the surgeries performed since March 2020 to a baseline of 2019 without considering population growth or other factors. The most substantial drop in surgeries occurred in the initial four months of the pandemic (March to June 2020), when many scheduled and non-urgent procedures were postponed or canceled across the country to align with public health guidelines.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global embolic protection devices market size was valued at USD 612.9 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030.

• The global bone densitometers market size was valued at USD 241.2 million in 2023 and is projected to grow at a CAGR of 4.5% from 2024 to 2030.

Global Sinus Dilation Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global sinus dilation devices market based on product, type, procedure, application, end use, and region.

Product Outlook (Revenue in USD Million, 2018 - 2030)

Ballon Sinus Dilation Devices

Endoscopes 

Sinus Stents/Implants 

Functional Endoscopic Sinus Surgery (FESS) Instruments Set

Others

Type Outlook (Revenue in USD Million, 2018 - 2030)

Sinuscopes

Rhinoscopes

Procedure Outlook (Revenue in USD Million, 2018 - 2030)

Standalone

Hybrid

Application Outlook (Revenue in USD Million, 2018 - 2030)

Adult

Pediatric

End-use Outlook (Revenue in USD Million, 2018 - 2030)

Hospitals 

Ambulatory Surgical Centers 

ENT Clinics/In Office

Regional Outlook (Revenue in USD Million, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa

South Africa

Saudi Arabia

UAE

Kuwait

Key Companies & Market Share Insights

Key players in the market are focusing on adopting growth strategies, such as mergers and acquisitions, developing existing devices, promotional events, and technological advancements. For instance, Intersect ENT, Inc., one of the leading medical technology companies for ear, nose, and throat care, introduced a new product in the U.S. called the Straight Delivery System (SDS) along with the PROPEL Mini Sinus Implant (a medical device). The U.S. Food and Drug Administration has approved this combined packaging, making it available for use. The Straight Delivery System was previously approved in July 2020. In simple terms, Intersect ENT has launched a new product in the U.S. that includes a medical device called the SDS and the PROPEL Mini Sinus Implant, which the FDA has approved for use:

Medtronic

Smith+Nephew

Stryker

Intersect ENT, Inc

Olympus Corporation

SinuSys Corporation

Johnson & Johnson Services, Inc.

TE Connectivity

InnAccel Technologies Pvt Ltd

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.

[padmavarma]

The Medical Equipment Optics Market is estimated to grow at a CAGR of 4% during the forecast period 2024-2030 and reach USD 36.5 billion by 2030, from around USD 28.1 billion 2023.

👉 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 @ https://tinyurl.com/3ccfuxby

Report CoverageThe report: “Medical Equipment Optics Market Forecast (2024-2030)" by IndustryARC, covers an in-depth analysis of the following segments of the Medical Equipment Optics Market.

By Optical Devices - Image Sensor, Optical Fiber, Fiber Sensor, IR Lamps, UV Lamps, Endoscopes and Others.

By Equipment - Blood Glucose Meters, Blood Pressure Meters, Laparoscope, Optometer, Diagnostic Imaging, XRF Instrument, In-Vitro Diagnostic Equipment, CT Equipment, Contrast Photography, Bone Densitometer and Others.

By End-users - Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Centers Or Laboratories and Research Organizations.

By Geography - North America (the US, Canada and Mexico), Europe (Germany, the UK, France, Italy, Spain, Russia and the Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia and New Zealand and the Rest of Asia Pacific), South America (Brazil, Argentina and Rest of South America) and the Rest of the World (the Middle East and Africa).

[omkarpatel]

Bone Densitometers Market is Estimated to Witness High Growth Owing to Opportunity in Early Disease Detection

Bone densitometers are medical devices used to measure bone loss due to osteoporosis or other bone-related diseases. Bone densitometers utilize technologies such as dual-energy x-ray absorptiometry (DXA), peripheral dual-energy x-ray absorptiometry (pDXA), quantitative computed tomography (QCT), and ultrasound densitometry to analyze bone mineral density. The devices are essential for diagnosing osteoporosis and monitoring treatment.

The global bone densitometers market is estimated to be valued at US$ 313.05 Mn in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity The ability of bone densitometers to detect osteoporosis and predict fracture risk in the early stages of the disease presents a lucrative opportunity for market growth. Osteoporosis, if left untreated, can lead to bone fractures. However, identifying the condition at an early stage allows preventive measures and medication that help preserve bone strength and prevent fractures. With growing awareness about bone health and aging populations worldwide, demand for bone densitometry procedures is rising. This is expected to significantly contribute to the revenue of bone densitometers over the forecast period. Porter’s Analysis Threat of new entrants: The bone densitometers market is difficult for new entrants to enter due to high capital investment required to manufacture bone densitometers and stringent regulations in place. However, advanced technologies and innovation by new entrants pose moderate threat. Bargaining power of buyers: The bargaining power of buyers is low in this market as bone densitometers are used mainly by hospitals and clinics. Buyers do not have many alternatives. Bargaining power of suppliers: A few large players dominate the supply side. Hence suppliers have strong bargaining power. Suppliers can influence price by developing novel technologies and solutions. Threat of new substitutes: There are limited substitutes for bone densitometers currently. Advanced body composition monitoring devices pose low-moderate threat as substitutes. Competitive rivalry: The market is consolidated with GE Healthcare, Hologic, Inc. and Swissray being the major players. High capital requirements and regulated nature attract fewer players resulting in high competition. SWOT Analysis Strength: Bone densitometers are non-invasive and painless techniques to accurately diagnose and monitor osteoporosis. New technologies offer improved precision and workflow efficiency. Weakness: Bone densitometers are expensive machines requiring high maintenance costs. Lack of awareness about osteoporosis in developing regions hampers market growth. Opportunity: Rising geriatric population prone to osteoporosis globally offers vast opportunities. Developing healthcare infrastructure expands patient access in emerging nations. Threats: Stringent regulations for new product approvals can delay market entry. Economic slowdowns affect hospital budgets limiting large capital investments. Key Takeaways The global bone densitometers market is expected to witness high growth during the forecast period of 2023-2030 driven by rapidly growing geriatric population worldwide and rising awareness about osteoporosis. The global Bone Densitometers Market is estimated to be valued at US$ 313.05 Mn in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023 to 2030.

Regional analysis shows North America dominates currently owing to advanced healthcare facilities and high healthcare spending. Asia Pacific is predicted to be the fastest growing market due to improving healthcare access and increasing healthcare investments. Key players operating in the bone densitometers market are GE Healthcare, Hologic, Inc., Swissray Global Healthcare Holding, and BeamMed Ltd. GE Healthcare holds the largest market share while Hologic, Inc. offers innovative solutions like dual energy x-ray absorptiometry. The market offers opportunities for new entrants by penetrating emerging countries and developing novel technologies with improved precision and workflow. Stringent regulations for launches may hamper fast entry of new players.

[techninja]

Peripheral DXA Machines and Beyond: Navigating the Diverse Bone Sonometer Market

The Bone Sonometer Market: Advancements in Osteoporosis Diagnosis and Beyond

The Bone Sonometer market is a thriving segment of the healthcare industry that plays a critical role in the diagnosis and management of osteoporosis and various other bone-related conditions. Osteoporosis, characterized by the weakening of bones and increased susceptibility to fractures, is a widespread health concern, especially among the aging population. Bone sonometers, also known as bone densitometers, have become indispensable tools for early detection, assessment, and monitoring of bone health. This article delves into the Bone Sonometer market, its growth drivers, emerging trends, and the broader impact of these devices on healthcare.

Understanding Bone Sonometers

Bone sonometers are specialized medical devices designed to measure bone mineral density (BMD) and assess the risk of bone fractures. They work on the principle of dual-energy X-ray absorptiometry (DXA) or ultrasound technology, providing precise data on bone density and helping healthcare professionals diagnose osteoporosis at its early stages. The global Bone Sonometer market includes various types of devices, such as central DXA machines, peripheral DXA machines, and quantitative ultrasound devices.

Growth Drivers

Several factors contribute to the growth of the Bone Sonometer market:

1. Aging Population: With an ever-increasing aging population, the prevalence of osteoporosis and related bone disorders is on the rise. Bone sonometers become crucial in managing this demographic's bone health.

2. Growing Awareness: There is a growing awareness of osteoporosis and its consequences. As individuals become more health-conscious, the demand for bone density assessments increases.

3. Advancements in Technology: Continuous technological advancements have made bone sonometers more efficient, accurate, and user-friendly, further fueling market growth.

4. Reimbursement Policies: The availability of reimbursement for bone density tests in many countries encourages patients to undergo these assessments, positively impacting the market.

Emerging Trends

1. Portable Devices: There is a rising demand for portable bone sonometers that can be used in point-of-care settings. These devices are more convenient for primary care physicians and can improve patient access to bone health assessments.

2. Telemedicine Integration: The integration of bone sonometers into telemedicine platforms allows for remote monitoring and consultations, making it easier for patients to receive expert advice and follow-up care.

3. AI and Data Analytics: Artificial intelligence and data analytics are being incorporated into bone sonometer software to enhance diagnostic accuracy and predictive modeling of bone health.

4. Multifunctional Machines: Some manufacturers are developing multifunctional machines that not only measure bone density but also assess body composition, muscle mass, and fat percentage. This provides a more comprehensive understanding of overall health.

5. Emerging Markets: The Bone Sonometer market is expanding in emerging markets as healthcare infrastructure and awareness improve. These regions offer substantial growth opportunities for market players.

Impact on Healthcare

The Bone Sonometer market has a significant impact on healthcare in several ways:

1. Early Detection and Prevention: Bone sonometers play a crucial role in the early detection of osteoporosis, enabling interventions that can prevent fractures and related complications.

2. Reduced Healthcare Costs: Timely bone density assessments and treatment can help reduce healthcare costs associated with treating fractures and their consequences.

3. Improved Quality of Life: By identifying individuals at risk for osteoporosis, bone sonometers contribute to better management of bone health, thus improving the quality of life for many.

In conclusion, the Bone Sonometer market is poised for continued growth as the global population ages and awareness of bone health increases. Technological advancements and emerging trends are reshaping the landscape of bone density assessment, offering new opportunities for healthcare professionals and patients. As the market continues to evolve, the impact on healthcare will be profound, enabling better bone health management and ultimately improving the overall well-being of individuals at risk for bone-related conditions.

Few Other Promising Reports in Medical Devices Industry

Anti-Obesity Drug Market

Angioplasty Balloons Market

Drug Eluting Balloon Market

PTA Balloon Catheter Market

[sophiareddy123]

The Bone Densitometer Systems Market is segmented by technology (Axial Bone Densitometry and Peripheral Bone Densitometry), End-User (Hospitals, Specialty Clinics, Other End Users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

Download Free Sample Report - Bone Densitometer Systems Market

[tamanna31]

Dermatology Devices 2024 Industry – Challenges, Drivers, Outlook, Segmentation - Analysis to 2030

Dermatology Devices Industry Overview

The global dermatology devices market size was valued at USD 15.29 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 12.64% from 2024 to 2030.

The increasing prevalence of skin cancer and other skin diseases is contributing largely to the high demand for the skin care instruments market. Furthermore, growing awareness among people about the aesthetic appeal and technological advancements in skin care instruments are also increasing the adoption of these devices significantly. The rise in disposable income is also considered as one of the important factors driving the market growth of dermatology devices.

Gather more insights about the market drivers, restrains and growth of the Dermatology Devices Market

Skin cancer prevalence is increasing, with melanoma and non-melanoma skin cancers rising. The Skin Cancer Foundation reports that every year in the U.S., approximately 10,130 people die due to melanoma. Additionally, according to the International Agency for Research on Cancer, globally, the number of new melanoma skin cancer is estimated to increase from 324,635 in 2020 to 413,132 by 2030. As a result, there is a growing demand for quick and accurate diagnosis of skin disorders, and it is expected to boost the market in forecast years.

The COVID-19 pandemic has affected various industries. Due to the pandemic, there has been a decrease in the number of patients visiting hospitals and clinics for non-essential medical procedures, including those related to dermatology. This has led to a decline in the demand for dermatological instruments, such as laser therapy and microdermabrasion instruments. However, the market for dermatological devices has seen a V shape recovery. With the successful rollout of vaccines in all regions, the volume of dermatological tools is beginning to recover to its pre-pandemic levels. In 2021, the market has witnessed high demand due to the backlog of 2020 and increased interest from people related to dermatological procedures. The dermatological devices market has witnessed high volatility during the past few months and is expected to return to its normal growth trend by 2023.

The dermatology devices market is developing rapidly due to growing aesthetic awareness. In the current scenario, people of all age groups are increasingly concerned about enhancing their aesthetic appeal. Complete skin rejuvenation improves the aesthetic appeal of a person. There has been a noticeable trend towards utilizing technologically advanced equipment in the field of dermatology. These devices help diagnose and treat various skin diseases accurately and improve one's overall appearance. The advent of non-invasive laser therapies has particularly led to a surge in demand for such advanced equipment.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global radiation dose monitoring market size was valued at USD 3.44 billion in 2023 and is projected to grow at a CAGR of 6.3% from 2024 to 2030.

• The global bone densitometers market size was valued at USD 241.2 million in 2023 and is projected to grow at a CAGR of 4.5% from 2024 to 2030.

Key Dermatology Devices Company Insights

Some of the key players operating in the market include Alma Lasers GmbH, Syneron Medical Ltd., Solta Medical, Inc., Cynosure, Ifnc., Cutera, Inc.

Alma Lasers is a company providing light-based, laser, ultrasound, and radiofrequency solutions in surgical and aesthetic fields. The company is present in over 80 countries across the globe. It operates through three major business segments: Surgical, beauty solutions, and medical aesthetic solutions.

Cynosure, Inc. is a manufacturer of light-based systems used in medical and aesthetic procedures. The company’s products are used in procedures such as body contouring, skin rejuvenation, hair removal, and scar reduction. It holds 37 patents and has its own distribution channel with subsidiaries in over 60 countries across the globe.

3Gen, Aesthetic Group, Ambicare Health, Image Derm, Inc are some of the emerging market participants in the dermatology devices market.

3Gen is a medical devices company engaged in manufacturing and marketing of DermLite. The company offers a wide range of dermatoscopes for diagnosis of various skin care conditions and diseases. Majority of the company’s products are used for skin cancer detection.

Image Derm, Inc. is a medical devices company engaged in manufacturing and marketing of microdermabrasion devices. The company offers products for crystal microdermabrasion, diamond microdermabrasion, and serum infusion. It offers its diverse products for various end-use settings such as beauty salons, dermatology clinics, and spas.

Key Dermatology Devices Companies

The following are the leading companies in the dermatology devices market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these dermatology devices companies are analyzed to map the supply network.

Alma Lasers GmbH

Cynosure, Inc.

Solta Medical, Inc.

Cutera, Inc.

Syneron Medical Ltd.

Canfield Scientific, Inc.

3Gen

Aesthetic Group

Ambicare Health

Image Derm, Inc.

Order a free sample PDF of the Dermatology Devices Market Intelligence Study, published by Grand View Research.